Advertisement

Index by author

March 01, 1988; Volume 16,Issue 2

A

  1. Atteba, S

    1. Pre- and postweaning development of drug-metabolizing enzyme activities in small intestine and liver of rats.
      I de Waziers, M Boisset and S Atteba
      Drug Metabolism and Disposition March 1988, 16 (2) 310-315;

B

  1. Baker, M T

    1. Metabolic activation of the halothane metabolite, [14C]2-chloro-1,1-difluoroethene, in hepatic microsomes.
      M T Baker and J N Bates
      Drug Metabolism and Disposition March 1988, 16 (2) 169-172;

  2. Bates, J N

    1. Metabolic activation of the halothane metabolite, [14C]2-chloro-1,1-difluoroethene, in hepatic microsomes.
      M T Baker and J N Bates
      Drug Metabolism and Disposition March 1988, 16 (2) 169-172;

  3. Baughman, R A

    1. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
      B L Ferraiolo, J A Moore, D Crase, P Gribling, H Wilking and R A Baughman
      Drug Metabolism and Disposition March 1988, 16 (2) 270-275;

  4. Beitner, D B

    1. Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver.
      W L Nelson, L D Olsen, D B Beitner and R J Pallow
      Drug Metabolism and Disposition March 1988, 16 (2) 184-188;

  5. Benet, L Z

    1. Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide.
      M L Hyneck, A Munafo and L Z Benet
      Drug Metabolism and Disposition March 1988, 16 (2) 322-324;

  6. Bertault-Peres, P

    1. Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
      I Fabre, G Fabre, P Maurel, P Bertault-Peres and J P Cano
      Drug Metabolism and Disposition March 1988, 16 (2) 296-301;

  7. Boisset, M

    1. Pre- and postweaning development of drug-metabolizing enzyme activities in small intestine and liver of rats.
      I de Waziers, M Boisset and S Atteba
      Drug Metabolism and Disposition March 1988, 16 (2) 310-315;

  8. Boyle, K E

    1. Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;

  9. Braham, Y

    1. The rat biliary and urinary metabolism of the N6-methylated derivative of elliptinium acetate, and antitumor agent.
      Y Braham, G Meunier and B Meunier
      Drug Metabolism and Disposition March 1988, 16 (2) 316-321;

  10. Buben, J A

    1. In vitro metabolism and covalent binding among ortho-substituted bromobenzenes of varying hepatotoxicity.
      P E Weller, N Narasimhan, J A Buben and R P Hanzlik
      Drug Metabolism and Disposition March 1988, 16 (2) 232-237;

C

  1. Caldwell, J

    1. The metabolism and disposition of fenofibrate in rat, guinea pig, and dog.
      A Weil, J Caldwell and M Strolin-Benedetti
      Drug Metabolism and Disposition March 1988, 16 (2) 302-309;

  2. Cano, J P

    1. Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
      I Fabre, G Fabre, P Maurel, P Bertault-Peres and J P Cano
      Drug Metabolism and Disposition March 1988, 16 (2) 296-301;

  3. Castagnoli, N

    1. Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes.
      D Di Monte, T Shinka, M S Sandy, N Castagnoli and M T Smith
      Drug Metabolism and Disposition March 1988, 16 (2) 250-255;

  4. Chan, T M

    1. Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;

  5. Coon, M J

    1. Cytochrome P-450-dependent formation of ethylene from N-nitrosoethylamines.
      X X Ding and M J Coon
      Drug Metabolism and Disposition March 1988, 16 (2) 265-269;

  6. Crase, D

    1. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
      B L Ferraiolo, J A Moore, D Crase, P Gribling, H Wilking and R A Baughman
      Drug Metabolism and Disposition March 1988, 16 (2) 270-275;

  7. Crysler, C S

    1. Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;

D

  1. D'Souza, M J

    1. Cyclosporine-phenytoin interaction.
      M J D'Souza, S H Pollock and H M Solomon
      Drug Metabolism and Disposition March 1988, 16 (2) 256-258;

  2. Dain, J G

    1. Effect of diet and gavage on the absorption and metabolism of fluperlapine in the rat.
      J G Dain and J M Jaffe
      Drug Metabolism and Disposition March 1988, 16 (2) 238-242;

  3. de Waziers, I

    1. Pre- and postweaning development of drug-metabolizing enzyme activities in small intestine and liver of rats.
      I de Waziers, M Boisset and S Atteba
      Drug Metabolism and Disposition March 1988, 16 (2) 310-315;

  4. Diamond, G L

    1. In vivo renal tubular secretion and metabolism of the disulfide of 2,3-dimercaptopropane-1-sulfonate.
      J R Stewart and G L Diamond
      Drug Metabolism and Disposition March 1988, 16 (2) 189-195;

  5. Digenis, G A

    1. Disposition and metabolism of double-labeled [3H and 14C] N-methyl-2-pyrrolidinone in the rat.
      D A Wells and G A Digenis
      Drug Metabolism and Disposition March 1988, 16 (2) 243-249;

  6. Di Monte, D

    1. Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes.
      D Di Monte, T Shinka, M S Sandy, N Castagnoli and M T Smith
      Drug Metabolism and Disposition March 1988, 16 (2) 250-255;

  7. Ding, X X

    1. Cytochrome P-450-dependent formation of ethylene from N-nitrosoethylamines.
      X X Ding and M J Coon
      Drug Metabolism and Disposition March 1988, 16 (2) 265-269;

F

  1. Fabre, G

    1. Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
      I Fabre, G Fabre, P Maurel, P Bertault-Peres and J P Cano
      Drug Metabolism and Disposition March 1988, 16 (2) 296-301;

  2. Fabre, I

    1. Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
      I Fabre, G Fabre, P Maurel, P Bertault-Peres and J P Cano
      Drug Metabolism and Disposition March 1988, 16 (2) 296-301;

  3. Ferraiolo, B L

    1. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
      B L Ferraiolo, J A Moore, D Crase, P Gribling, H Wilking and R A Baughman
      Drug Metabolism and Disposition March 1988, 16 (2) 270-275;

  4. Fong, K L

    1. Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;

  5. Franklin, M R

    1. N-benzylimidazole, a high magnitude inducer of rat hepatic cytochrome P-450 exhibiting both polycyclic aromatic hydrocarbon- and phenobarbital-type induction of phase I and phase II drug-metabolizing enzymes.
      D I Papac and M R Franklin
      Drug Metabolism and Disposition March 1988, 16 (2) 259-264;

  6. Frey, B M

    1. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
      B M Frey, M Sieber, D Mettler, H Gänger and F J Frey
      Drug Metabolism and Disposition March 1988, 16 (2) 285-289;

  7. Frey, F J

    1. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
      B M Frey, M Sieber, D Mettler, H Gänger and F J Frey
      Drug Metabolism and Disposition March 1988, 16 (2) 285-289;

G

  1. Gänger, H

    1. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
      B M Frey, M Sieber, D Mettler, H Gänger and F J Frey
      Drug Metabolism and Disposition March 1988, 16 (2) 285-289;

  2. Garnes, D

    1. Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
      W H Wu, B M Henderson, R Lanc, D Garnes, A Yacobi and B M Silber
      Drug Metabolism and Disposition March 1988, 16 (2) 222-227;

  3. Giacomini, K M

    1. Inhibition of cimetidine transport by creatinine in luminal membrane vesicles prepared from rabbit kidney.
      L G Gisclon and K M Giacomini
      Drug Metabolism and Disposition March 1988, 16 (2) 331-332;

  4. Girijavallabhan, V M

    1. Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;

  5. Gisclon, L G

    1. Inhibition of cimetidine transport by creatinine in luminal membrane vesicles prepared from rabbit kidney.
      L G Gisclon and K M Giacomini
      Drug Metabolism and Disposition March 1988, 16 (2) 331-332;

  6. Glass, S J

    1. Metabolism of 7-ethoxyresorufin by phenobarbital or Aroclor 1254 pretreated mice.
      S J Glass and R B van Lier
      Drug Metabolism and Disposition March 1988, 16 (2) 333-334;

  7. Gribling, P

    1. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
      B L Ferraiolo, J A Moore, D Crase, P Gribling, H Wilking and R A Baughman
      Drug Metabolism and Disposition March 1988, 16 (2) 270-275;

  8. Gustavson, L M

    1. Regioisomeric products of propranolol metabolism. The monomethyl ethers of 3,4-dihydroxypropranolol and of 3,4-dihydroxypropranolol glycol.
      L M Gustavson and W L Nelson
      Drug Metabolism and Disposition March 1988, 16 (2) 217-221;

H

  1. Hall, I H

    1. The disposition of the hypolipidemic agent, o-(N-phthalimido)acetophenone, in Sprague-Dawley rats.
      I H Hall, D J Reynolds, S D Wyrick, J H Maguire and R P Shrewsbury
      Drug Metabolism and Disposition March 1988, 16 (2) 196-200;

  2. Hanano, M

    1. Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
      T H Lin, Y Sugiyama, Y Sawada, S Kawasaki, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 290-295;
    2. Efflux of cimetidine from the rat cerebrospinal fluid.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 328-330;

  3. Hanzlik, R P

    1. In vitro metabolism and covalent binding among ortho-substituted bromobenzenes of varying hepatotoxicity.
      P E Weller, N Narasimhan, J A Buben and R P Hanzlik
      Drug Metabolism and Disposition March 1988, 16 (2) 232-237;

  4. Henderson, B M

    1. Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
      W H Wu, B M Henderson, R Lanc, D Garnes, A Yacobi and B M Silber
      Drug Metabolism and Disposition March 1988, 16 (2) 222-227;

  5. Hyneck, M L

    1. Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide.
      M L Hyneck, A Munafo and L Z Benet
      Drug Metabolism and Disposition March 1988, 16 (2) 322-324;

I

  1. Iga, T

    1. Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
      T H Lin, Y Sugiyama, Y Sawada, S Kawasaki, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 290-295;
    2. Efflux of cimetidine from the rat cerebrospinal fluid.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 328-330;

J

  1. Jaffe, J M

    1. Effect of diet and gavage on the absorption and metabolism of fluperlapine in the rat.
      J G Dain and J M Jaffe
      Drug Metabolism and Disposition March 1988, 16 (2) 238-242;

K

  1. Kannan, R

    1. Dose-dependent tissue uptake of flecainide during chronic administration in rabbits.
      R Kannan and A Matin-Asgari
      Drug Metabolism and Disposition March 1988, 16 (2) 228-231;

  2. Kawasaki, S

    1. Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
      T H Lin, Y Sugiyama, Y Sawada, S Kawasaki, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 290-295;

  3. Kim, H

    1. Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;

  4. Kopaciewicz, L

    1. Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;

  5. Kopia, G A

    1. Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;

L

  1. Lanc, R

    1. Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
      W H Wu, B M Henderson, R Lanc, D Garnes, A Yacobi and B M Silber
      Drug Metabolism and Disposition March 1988, 16 (2) 222-227;

  2. Lapiguera, A

    1. Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;

  3. Lin, C

    1. Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;

  4. Lin, T H

    1. Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
      T H Lin, Y Sugiyama, Y Sawada, S Kawasaki, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 290-295;

  5. Lynn, R K

    1. Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;

M

  1. Maguire, J H

    1. The disposition of the hypolipidemic agent, o-(N-phthalimido)acetophenone, in Sprague-Dawley rats.
      I H Hall, D J Reynolds, S D Wyrick, J H Maguire and R P Shrewsbury
      Drug Metabolism and Disposition March 1988, 16 (2) 196-200;

  2. Matin-Asgari, A

    1. Dose-dependent tissue uptake of flecainide during chronic administration in rabbits.
      R Kannan and A Matin-Asgari
      Drug Metabolism and Disposition March 1988, 16 (2) 228-231;

  3. Maurel, P

    1. Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions.
      I Fabre, G Fabre, P Maurel, P Bertault-Peres and J P Cano
      Drug Metabolism and Disposition March 1988, 16 (2) 296-301;

  4. Mettler, D

    1. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
      B M Frey, M Sieber, D Mettler, H Gänger and F J Frey
      Drug Metabolism and Disposition March 1988, 16 (2) 285-289;

  5. Meunier, B

    1. The rat biliary and urinary metabolism of the N6-methylated derivative of elliptinium acetate, and antitumor agent.
      Y Braham, G Meunier and B Meunier
      Drug Metabolism and Disposition March 1988, 16 (2) 316-321;

  6. Meunier, G

    1. The rat biliary and urinary metabolism of the N6-methylated derivative of elliptinium acetate, and antitumor agent.
      Y Braham, G Meunier and B Meunier
      Drug Metabolism and Disposition March 1988, 16 (2) 316-321;

  7. Mico, B A

    1. Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.
      K L Fong, C S Crysler, B A Mico, K E Boyle, G A Kopia, L Kopaciewicz and R K Lynn
      Drug Metabolism and Disposition March 1988, 16 (2) 201-206;

  8. Moore, J A

    1. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
      B L Ferraiolo, J A Moore, D Crase, P Gribling, H Wilking and R A Baughman
      Drug Metabolism and Disposition March 1988, 16 (2) 270-275;

  9. Munafo, A

    1. Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide.
      M L Hyneck, A Munafo and L Z Benet
      Drug Metabolism and Disposition March 1988, 16 (2) 322-324;

N

  1. Narasimhan, N

    1. In vitro metabolism and covalent binding among ortho-substituted bromobenzenes of varying hepatotoxicity.
      P E Weller, N Narasimhan, J A Buben and R P Hanzlik
      Drug Metabolism and Disposition March 1988, 16 (2) 232-237;

  2. Nelson, W L

    1. Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver.
      W L Nelson, L D Olsen, D B Beitner and R J Pallow
      Drug Metabolism and Disposition March 1988, 16 (2) 184-188;
    2. Regioisomeric aromatic dihydroxylation of propranolol. Use of monohydroxylated intermediates for structural assignments of the metabolites formed in vitro.
      R E Talaat and W L Nelson
      Drug Metabolism and Disposition March 1988, 16 (2) 207-211;
    3. Regioisomeric aromatic dihydroxylation of propranolol. Synthesis and identification of 4,6- and 4,8-dihydroxypropranolol as metabolites in the rat and in man.
      R E Talaat and W L Nelson
      Drug Metabolism and Disposition March 1988, 16 (2) 212-216;
    4. Regioisomeric products of propranolol metabolism. The monomethyl ethers of 3,4-dihydroxypropranolol and of 3,4-dihydroxypropranolol glycol.
      L M Gustavson and W L Nelson
      Drug Metabolism and Disposition March 1988, 16 (2) 217-221;

  3. Neumann, H G

    1. Modulation of trans-4-acetylaminostilbene metabolism in the rat by methylcholanthrene and phenobarbital and its relevance for acute toxicity.
      A Pfeifer and H G Neumann
      Drug Metabolism and Disposition March 1988, 16 (2) 276-284;

O

  1. Olsen, L D

    1. Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver.
      W L Nelson, L D Olsen, D B Beitner and R J Pallow
      Drug Metabolism and Disposition March 1988, 16 (2) 184-188;

P

  1. Pallow, R J

    1. Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver.
      W L Nelson, L D Olsen, D B Beitner and R J Pallow
      Drug Metabolism and Disposition March 1988, 16 (2) 184-188;

  2. Papac, D I

    1. N-benzylimidazole, a high magnitude inducer of rat hepatic cytochrome P-450 exhibiting both polycyclic aromatic hydrocarbon- and phenobarbital-type induction of phase I and phase II drug-metabolizing enzymes.
      D I Papac and M R Franklin
      Drug Metabolism and Disposition March 1988, 16 (2) 259-264;

  3. Pfeifer, A

    1. Modulation of trans-4-acetylaminostilbene metabolism in the rat by methylcholanthrene and phenobarbital and its relevance for acute toxicity.
      A Pfeifer and H G Neumann
      Drug Metabolism and Disposition March 1988, 16 (2) 276-284;

  4. Pollock, S H

    1. Cyclosporine-phenytoin interaction.
      M J D'Souza, S H Pollock and H M Solomon
      Drug Metabolism and Disposition March 1988, 16 (2) 256-258;

  5. Pramanik, B

    1. Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;

R

  1. Reynolds, D J

    1. The disposition of the hypolipidemic agent, o-(N-phthalimido)acetophenone, in Sprague-Dawley rats.
      I H Hall, D J Reynolds, S D Wyrick, J H Maguire and R P Shrewsbury
      Drug Metabolism and Disposition March 1988, 16 (2) 196-200;

S

  1. Sandy, M S

    1. Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes.
      D Di Monte, T Shinka, M S Sandy, N Castagnoli and M T Smith
      Drug Metabolism and Disposition March 1988, 16 (2) 250-255;

  2. Sawada, Y

    1. Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
      T H Lin, Y Sugiyama, Y Sawada, S Kawasaki, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 290-295;
    2. Efflux of cimetidine from the rat cerebrospinal fluid.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 328-330;

  3. Shinka, T

    1. Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes.
      D Di Monte, T Shinka, M S Sandy, N Castagnoli and M T Smith
      Drug Metabolism and Disposition March 1988, 16 (2) 250-255;

  4. Shou, M

    1. Regioselective and stereoselective metabolisms of pyrene and 1-bromopyrene by rat liver microsomes and effects of enzyme inducers.
      M Shou and S K Yang
      Drug Metabolism and Disposition March 1988, 16 (2) 173-183;

  5. Shrewsbury, R P

    1. The disposition of the hypolipidemic agent, o-(N-phthalimido)acetophenone, in Sprague-Dawley rats.
      I H Hall, D J Reynolds, S D Wyrick, J H Maguire and R P Shrewsbury
      Drug Metabolism and Disposition March 1988, 16 (2) 196-200;

  6. Sieber, M

    1. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
      B M Frey, M Sieber, D Mettler, H Gänger and F J Frey
      Drug Metabolism and Disposition March 1988, 16 (2) 285-289;

  7. Silber, B M

    1. Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
      W H Wu, B M Henderson, R Lanc, D Garnes, A Yacobi and B M Silber
      Drug Metabolism and Disposition March 1988, 16 (2) 222-227;

  8. Smith, M T

    1. Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes.
      D Di Monte, T Shinka, M S Sandy, N Castagnoli and M T Smith
      Drug Metabolism and Disposition March 1988, 16 (2) 250-255;

  9. Solomon, H M

    1. Cyclosporine-phenytoin interaction.
      M J D'Souza, S H Pollock and H M Solomon
      Drug Metabolism and Disposition March 1988, 16 (2) 256-258;

  10. Stewart, J R

    1. In vivo renal tubular secretion and metabolism of the disulfide of 2,3-dimercaptopropane-1-sulfonate.
      J R Stewart and G L Diamond
      Drug Metabolism and Disposition March 1988, 16 (2) 189-195;

  11. Strolin-Benedetti, M

    1. The metabolism and disposition of fenofibrate in rat, guinea pig, and dog.
      A Weil, J Caldwell and M Strolin-Benedetti
      Drug Metabolism and Disposition March 1988, 16 (2) 302-309;

  12. Sugiyama, Y

    1. Effect of serum from renal failure and cirrhotic patients on the blood-brain barrier permeability to DL-propranolol in rats.
      T H Lin, Y Sugiyama, Y Sawada, S Kawasaki, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 290-295;
    2. Efflux of cimetidine from the rat cerebrospinal fluid.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 328-330;

  13. Suzuki, H

    1. Efflux of cimetidine from the rat cerebrospinal fluid.
      H Suzuki, Y Sawada, Y Sugiyama, T Iga and M Hanano
      Drug Metabolism and Disposition March 1988, 16 (2) 328-330;

  14. Symchowicz, S

    1. Identification of two metabolites of a penem (Sch 34343) in human urine.
      H Kim, B Pramanik, A Lapiguera, T M Chan, V M Girijavallabhan, S Symchowicz and C Lin
      Drug Metabolism and Disposition March 1988, 16 (2) 325-327;

T

  1. Talaat, R E

    1. Regioisomeric aromatic dihydroxylation of propranolol. Use of monohydroxylated intermediates for structural assignments of the metabolites formed in vitro.
      R E Talaat and W L Nelson
      Drug Metabolism and Disposition March 1988, 16 (2) 207-211;
    2. Regioisomeric aromatic dihydroxylation of propranolol. Synthesis and identification of 4,6- and 4,8-dihydroxypropranolol as metabolites in the rat and in man.
      R E Talaat and W L Nelson
      Drug Metabolism and Disposition March 1988, 16 (2) 212-216;

V

  1. van Lier, R B

    1. Metabolism of 7-ethoxyresorufin by phenobarbital or Aroclor 1254 pretreated mice.
      S J Glass and R B van Lier
      Drug Metabolism and Disposition March 1988, 16 (2) 333-334;

W

  1. Weil, A

    1. The metabolism and disposition of fenofibrate in rat, guinea pig, and dog.
      A Weil, J Caldwell and M Strolin-Benedetti
      Drug Metabolism and Disposition March 1988, 16 (2) 302-309;

  2. Weller, P E

    1. In vitro metabolism and covalent binding among ortho-substituted bromobenzenes of varying hepatotoxicity.
      P E Weller, N Narasimhan, J A Buben and R P Hanzlik
      Drug Metabolism and Disposition March 1988, 16 (2) 232-237;

  3. Wells, D A

    1. Disposition and metabolism of double-labeled [3H and 14C] N-methyl-2-pyrrolidinone in the rat.
      D A Wells and G A Digenis
      Drug Metabolism and Disposition March 1988, 16 (2) 243-249;

  4. Wilking, H

    1. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
      B L Ferraiolo, J A Moore, D Crase, P Gribling, H Wilking and R A Baughman
      Drug Metabolism and Disposition March 1988, 16 (2) 270-275;

  5. Wu, W H

    1. Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
      W H Wu, B M Henderson, R Lanc, D Garnes, A Yacobi and B M Silber
      Drug Metabolism and Disposition March 1988, 16 (2) 222-227;

  6. Wyrick, S D

    1. The disposition of the hypolipidemic agent, o-(N-phthalimido)acetophenone, in Sprague-Dawley rats.
      I H Hall, D J Reynolds, S D Wyrick, J H Maguire and R P Shrewsbury
      Drug Metabolism and Disposition March 1988, 16 (2) 196-200;

Y

  1. Yacobi, A

    1. Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
      W H Wu, B M Henderson, R Lanc, D Garnes, A Yacobi and B M Silber
      Drug Metabolism and Disposition March 1988, 16 (2) 222-227;

  2. Yang, S K

    1. Regioselective and stereoselective metabolisms of pyrene and 1-bromopyrene by rat liver microsomes and effects of enzyme inducers.
      M Shou and S K Yang
      Drug Metabolism and Disposition March 1988, 16 (2) 173-183;
Back to top

In this issue

Advertisement